Prof. Dr. med. Friedrich Stoelzell
internal medicine, hematology, oncology, and immunotherapy
internal medicine, hematology, oncology, and immunotherapy
Overview
Country, City
Germany, Kiel
Health facility
University Hospital Schleswig-Holstein Kiel
Medical unit
Department of stem cell and immunotherapy
About the doctor
Skills & Expertise
leukemia
myeloid leukemia
stem cell
stem cell transplantation
immunotherapy
cancer
myelodysplastic syndrome
bone
bone marrow
hematology
oncology
stromal cells
internal medicine
hematopoiesis
promyelocytic leukemia
blood marrow
mutation
multiple myeloma
myeloma
blood marrow transplantation
mesenchymal stromal cells
myeloid neoplasm
myeloid sarcoma
cell immunotherapy
breast cancer
cytarabine
clofarabine
stem cell immunotherapy
breast
sarcoma
abnormalities
neoplasm
cyclophosphamide
peripheral blood stem
myelofibrosis
myelogenous leukemia
amsacrine
decitabine
haemopoietic stem
lymphocytic leukaemia
elderly
steroidrefractory graft
aplasia
radioimmunotherapy
chromosomal abnormalities
gastrointestinal tract
weight loss
coagulopathy
flotetuzumab
hyperfibrinolysis
Resume
CV (Curriculum Vitae)
Education
- Studied human medicine at the Dresden University of Technology
- Obtaining a license for medical practice
- Defense of the dissertation at the Dresden University of Technology
- Studied psychology in Muenster
- Obtaining specialization in internal medicine
- Habilitation and a teaching license
- Received additional qualifications in the field of hematology and oncology
Experience
- Basic military service
- Practical year at the Harvard Medical School in Boston
- Medical doctor at University Hospital in Dresden
- Head of the Department of stem cell and immunotherapy at the University Hospital Schleswig-Holstein Kiel (UKSH)
Languages
English
German
Publications
Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
September, 2023
Allogeneic hematopoietic cell transplantation for patients with AML aged 70 years or older in first remission. A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
September, 2023
Discriminant Principal Component Analysis of ToF-SIMS Spectra for Deciphering Compositional Differences of MSC-Secreted Extracellular Matrices.
June, 2023
Location
Arnold-Heller-Str, 3, 24105 Kiel, Germany
FAQ
Where does the doctor practice?
What is the specialization of Prof. Dr. med. Friedrich Stoelzell?
The primary specialization of the doctor is internal medicine, hematology, oncology, and immunotherapy.
What is the rating of the doctor?
Prof. Dr. med. Friedrich Stoelzell is rated as 9.90 by AiroMedical.
Prof. Dr. med. Friedrich Stoelzell
Get individual treatment plan and cost estimate. Non-binding 100% free assessment.
© Prof. Dr. med. Friedrich Stoelzell